Gilead’s cell therapy subsidiary Kite Pharma is letting go of roughly 300 employees, or about 7% of the unit’s staff. “We are taking measures to further align our business for future growth, including streamlining some […]
The FDA is reviewing the safety of CAR-T therapies after reports of patients who developed blood cancers following treatment with the products, an inquiry that’s almost certain to raise questions about the class as its […]
The company hopes to win FDA approval of its blood cancer drug imetelstat by mid-June. Click here to view original post Click here to view San Francisco Biotech Networks Trending News
“I plan to foster our organization’s growth in the next year. We’ll embark on ambitious initiatives and enhance our industry presence through networking,” she said. Click here to view original post Click here to view […]
Sutter Health’s finances, which had been positive all year, took a turn in the most recent quarter. Click here to view original post Click here to view San Francisco Biotech Networks Trending News
As public markets have slowed for biotech companies, including some that went public as generalist investors pumped money into the sector only two or three years ago, a handful are looking at going private. Click […]
The FDA on Tuesday released a warning letter that it sent to a clinical investigator involved in Genentech’s Phase IIIb trial for the antiviral Xofluza (baloxavir marboxil) for reducing flu transmission from otherwise healthy patients […]
“As CEO, true achievement stems from amplifying the potential of those around me,” he said. Click here to view original post Click here to view San Francisco Biotech Networks Trending News
Roche’s Genentech unit and Nvidia, the supercomputing hardware powerhouse, have signed a multi-year deal to speed up the pharma’s R&D work by using artificial intelligence, the companies said Tuesday. The partnership is the latest step […]
The founder and CEO of the startup worked on groundbreaking hepatitis C drugs as well as less-successful “fatty liver” drugs at Gilead Sciences. Click here to view original post Click here to view San Francisco […]
© 2023 Biotech Networks, LLC
